2021 Vol.2 Sept.No4

• Title: Epidemiological characteristics of cardiovascular and cerebrovascular complications in patients with chronic kidney disease
• Name: katsushika hokusai,Ono Kenichi
• Company: (Osaka Yinla University,Fengzhong 556-0015,Japan)
• Abstract:

  Objective: To understand the incidence of cardiovascular and cerebrovascular complications in patients with chronic kidney disease and analyze the risk factors of cardiovascular and cerebrovascular complications. Methods: 200 cases of cardiovascular and cerebrovascular patients with chronic kidney disease were divided into cardiovascular and cerebrovascular complications group (disease group) and non-vascular diseases group (no disease group), with 100 cases in each group. The incidence of cardiovascular and cerebrovascular complications, the interaction between chronic kidney disease and cardiovascular and cerebrovascular complications were analyzed. Methods: 168 cases of cardiovascular and cerebrovascular patients with chronic kidney disease were divided into cardiovascular and cerebrovascular complication group (disease group) and non-vascular disease group (no disease group) with 84 cases each, and the incidence of cardiovascular and cerebrovascular complications, the interaction between chronic kidney disease and cardiovascular and cerebrovascular complications were analyzed. Results: Cardiovascular and cerebrovascular complications mostly occur in women, and the higher the age, the higher the disease probability. The main complications are hypertension > diabetes > heart disease > hyperlipidemia > anemia, etc. Conclusion: Age is one of the risk factors of cardiovascular and cerebrovascular complications, so it is necessary to find out the complications and severity of chronic kidney diseases as early as possible, pay attention to the influence of hypertension, diabetes, heart diseases, hyperlipidemia, anemia and other factors on chronic kidney diseases, and take routine drug treatment in time.

  
  

• Keyword: Chronic kidney disease; Cardiovascular and cerebrovascular complications; Epidemiology; Research characteristics
• DOI: 10.12250/jpcarme2021020429
• Citation form: katsushika hokusai,Ono Kenichi.Epidemiological characteristics of cardiovascular and cerebrovascular complications in patients with chronic kidney disease.2020, vol. 3, 38-43.

[1]Atsushi H, Takashi N, Satoko E, et al. Clinical utility of evaluating intracranial artery stenosis and silent brain infarction to predict the presence of subclinical coronary artery disease in ischemic stroke patients[J]. Internal medicine (Tokyo, Japan), 2008, 47(20):1775-1781.

[2]De, Mello, Walmor, et al. Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases[J]. The Medical Clinics of North America, 2017, 101(1):117-127.

[3]Andonis K, Joaquin J, Hanna K. VDAC-Targeted Drugs Affecting Cytoprotection and Mitochondrial Physiology in Cerebrovascular and Cardiovascular Diseases[J].Current medicinal chemistry,2017,24(40):4419-4434.

[4]Warren J. The future of coronary heart disease prevention[J]. Clinical medicine: journal of the Royal College of Physicians of London, 2007,7(4):392-396.

[5]Lutski M, Haratz S, Weinstein G, et al. Impaired Cerebral Hemodynamics and Frailty in Patients with Cardiovascular Disease[J].The journals of gerontology.Series A. Biological sciences and medical sciences,2018,73(12):1714-1721.

[6]Bothun M L, Haaland O A, Logallo N, et al. Cerebrovascular reactivity after treatment of unruptured intracranial aneurysms - A transcranial Doppler sonography and acetazolamide study[J].Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology,2016,363(1):97-103.

[7]Boreskie K F, Kehler D S, Costa E C, et al. Standardization of the Fried frailty phenotype improves cardiovascular disease risk discrimination[J].Experimental Gerontology,2019,119(1):40-44.

[8]Weinstein G, Lutski M, Goldbourt U, et al. Physical frailty and cognitive function among men with cardiovascular disease[J].Archives of Gerontology and Geriatrics: An International Journal Integrating Experimental, Clinical and Social Studies on Ageing,2018,78(1):1-6.